Optimal use of fresh frozen plasma

Journal of Infusion Nursing

Volumn 35, Issue 1, 2012, Pages 28-32

  Dombourian, Melkon ^a   Holland, Lorne ^b  

^a UNIVERSITY OF COLORADO HOSPITAL   (United States)

^b PathGroup Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBIN; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 12; BLOOD CLOTTING FACTOR 13; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 PLUS VON WILLEBRAND FACTOR; COMPLEMENT COMPONENT C1S INHIBITOR; DIPHENHYDRAMINE; FIBRINOGEN; FRESH FROZEN PLASMA; PARACETAMOL; PROTEIN C; PROTHROMBIN; PROTHROMBIN COMPLEX; VITAMIN K GROUP; VON WILLEBRAND FACTOR; WARFARIN;

ACUTE HEPATITIS; ALLERGIC REACTION; ANAPHYLAXIS; BLEEDING; BLOOD CLOTTING FACTOR 13 DEFICIENCY; BLOOD TRANSFUSION REACTION; BRONCHOSPASM; CHILL; DENGUE VIRUS; DYSPNEA; FEVER; FLANK PAIN; HEMOPHILIA; HEMOPHILIA B; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOTENSION; HYPOXIA; MORBIDITY; MORTALITY; PARTIAL THROMBOPLASTIN TIME; PARVOVIRUS; PLASMA TRANSFUSION; PRION; PRIORITY JOURNAL; REVIEW; THAWING; THORAX PAIN; THROMBOTIC THROMBOCYTOPENIC PURPURA; TRANSFUSION RELATED ACUTE LUNG INJURY; TRYPANOSOMA CRUZI; VIRUS TRANSMISSION; WEST NILE FEVER;

BLOOD COMPONENT TRANSFUSION; DECISION MAKING; HUMANS; INFUSIONS, INTRAVENOUS; PLASMA; RISK FACTORS;

EID: 84855713143     PISSN: 15331458     EISSN: 15390667     Source Type: Journal    
DOI: 10.1097/NAN.0b013e31823b9a2b     Document Type: Review

References (29)

1. Whitaker BI, Green J, King MR, et al. The 2007 National Blood Collection and Utilization Survey Report. Rockville, MD: US Department of Health and Human Services; 2007.
2. Roback JD, Combs MR, Grossman B, Hillyer C. Technical Manual. 16th ed. Bethesda, MD: AABB; 2008.
3. Dodd RY. Current risk for transfusion transmitted infections. Curr Opin Hematol. 2007;14(6):671-676. (Pubitemid 47494085)
4. Perkins HA, Busch MP. Transfusion-associated infections: 50 years of relentless challenges and remarkable progress. Transfusion. 2010; 50(10):2080-2099.
5. Lindholm PF, Annen K, Ramsey G. Approaches to minimize infection risk in blood banking and transfusion practice. Infect Disord Drug Targets. 2011;11(1):45-56.
6. Walther-Wenke G. Incidence of bacterial transmission and transfusion reactions by blood components. Clin Chem Lab Med. 2008; 46(7):919-925.
7. Vamvakas EC, Blajchman MA. Blood still kills: six strategies to further reduce allogeneic blood transfusion-related mortality. Transfus Med Rev. 2010;24(2):77-124.
8. Toy P, Lowell C. TRALI-definition, mechanisms, incidence and clinical relevance. Best Pract Res Clin Anaesthesiol. 2007;21(2):183-193. (Pubitemid 46888184)
9. Silliman CC, Boshkov LK, Mehdizadehkashi Z, et al. Transfusionrelated acute lung injury: epidemiology and a prospective analysis of etiologic factors. Blood. 2003;101(2):454-462.
10. Gajic O, Rana R, Winters JL, et al. Transfusion-related acute lung injury in the critically ill: prospective nested case-control study. Am J Respir Crit Care Med. 2007;176(9):886-891. (Pubitemid 350097078)
11. Benson AB, Austin GL, Berg M, et al. Transfusion-related acute lung injury in ICU patients admitted with gastrointestinal bleeding. Intensive Care Med. 2010;36(10):1710-1717.
12. Reutter JC, Sanders KF, Brecher ME, Jones HG, Bandarenko N. Incidence of allergic reactions with fresh frozen plasma or cryo-supernatant plasma in the treatment of thrombotic thrombocytopenic purpura. J Clin Apher. 2001;16(3):134-138. (Pubitemid 32988801)
13. Sheedy W, Stewart AG, Morice AH. Plasma levels of atrial natriuretic peptide and brain natriuretic peptide following intravenous saline infusion in oedematous chronic obstructive pulmonary disease and non-oedematous chronic obstructive pulmonary disease. Respiration. 1996;63(6):376-380. (Pubitemid 26356676)
14. Matsumoto N, Akaike M, Nishiuchi T, Kawai H, Saito S. Different secretion profiles of atrial and brain natriuretic peptides after acute volume loading in patients with ischemic heart disease. Acta Cardiol. 1997;52(3):261-272. (Pubitemid 27334162)
15. Rana R, Fernández-Pérez ER, Khan SA, et al. Transfusion-related acute lung injury and pulmonary edema in critically ill patients: a retrospective study. Transfusion. 2006;46(9):1478-1483. (Pubitemid 44326320)
16. Li G, Rachmale S, Kojicic M, et al. Incidence and transfusion risk factors for transfusion-associated circulatory overload among medical intensive care unit patients. Transfusion. 2011;51(2):338-343.
17. Fry JL, Arnold DM, Clase CM, et al. Transfusion premedication to prevent acute transfusion reactions: a retrospective observational study to assess current practices. Transfusion. 2010;50(8):1722-1730.
18. Holcomb JB, Wade CE, Michalek JE, et al. Increased plasma and platelet to red blood cell ratios improves outcome in 466 massively transfused civilian trauma patients. Ann Surg. 2008;248(3):447-458.
19. Holland LL, Brooks JP. Toward rational fresh frozen plasma transfusion: the effect of plasma transfusion on coagulation test results. Am J Clin Pathol. 2006;126(1):133-139. (Pubitemid 44025082)
20. Thumboo J, O'Duffy JD. A prospective study of the safety of joint and soft tissue aspirations and injections in patients taking warfarin sodium. Arthritis Rheum. 1998;41(4):736-739. (Pubitemid 28214994)
21. ten Berg JM, Hutten BA, Kelder JC, Verheugt FW, Plokker HW. Oral anticoagulant therapy during and after coronary angioplasty the intensity and duration of anticoagulation are essential to reduce thrombotic complications. Circulation. 2001;103(16):2042-2047. (Pubitemid 32373005)
22. McCormack P, Simcock PR, Tullo AB. Management of the anticoagulated patient for ophthalmic surgery. Eye (Lond). 1993;7(6):749-750. (Pubitemid 24013284)
23. Evans IL, Sayers MS, Gibbons AJ, Price G, Snooks H, Sugar AW. Can warfarin be continued during dental extraction? Results of a randomized controlled trial. Oral Maxillofac Surg. 2002;40(3):248-252. (Pubitemid 34760054)
24. Abdel-Wahab OI, Healy B, Dzik WH. Effect of fresh-frozen plasma transfusion on prothrombin time and bleeding in patients with mild coagulation abnormalities. Transfusion. 2006;46(8):1279-1285. (Pubitemid 44117952)
25. McVay PA, Toy PT. Lack of increased bleeding after paracentesis and thoracentesis in patients with mild coagulation abnormalities. Transfusion. 1991;31(2):164-171.
26. Friedman EW, Sussman II. Safety of invasive procedures in patients with the coagulopathy of liver disease. Clin Lab Haematol. 1989;11(3):199-204. (Pubitemid 19249374)
27. Inabnet WB, Deziel DJ. Laparoscopic liver biopsy in patients with coagulopathy, portal hypertension, and ascites. Am Surg. 1995;61(7):603-606.
28. Makris M, van Veen JJ, Maclean R. Warfarin anticoagulation reversal: management of the asymptomatic and bleeding patient. J Thromb Thrombolysis. 2010;29(2):171-181.
29. Rolfe S, Papadopoulos S, Cabral KP. Controversies of anticoagulation reversal in life-threatening bleeds. J Pharm Pract. 2010;23(3):217-225.